Quick Answer
Profound Medical Corp. reported Stockholders Equity of $66.43 million for the year ending 2025.
- Profound Medical Corp. showed an increase of +10.0% in Stockholders Equity from 2024 to 2025.
- This data is from Profound Medical Corp.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $45.52 million | Q2 2024: $38.90 million | Q3 2024: $30.72 million | Q1 2025: $50.79 million | Q2 2025: $39.26 million | Q3 2025: $32.14 million.
- Over the full 4 years of available data (2022 to 2025), Profound Medical Corp.'s Stockholders Equity has grown by 26.3%.
- Historical annual values: Fiscal year 2025: $66.43 million | Fiscal year 2024: $60.42 million | Fiscal year 2023: $31.22 million | Fiscal year 2022: $52.60 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: